Caxton Associates (New York)’s Corcept Therapeutics CORT Stock Holding History

Caxton Associates (New York)’s Portfolio CORT Stock Details CORT Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$536K	Buy
2020 Q3	–	Sell
2020 Q2	$895K	Buy
2020 Q1	$275K	Buy
2019 Q4	$262K	Buy
2017 Q4	–	Sell
2017 Q3	$199K	Buy